Skip to main content
Top
Published in: Inflammation 6/2008

01-12-2008

Effects of All-Trans Retinoic Acid on Th1- and Th2-Related Chemokines Production in Monocytes

Authors: Yu-Chien Tsai, Hui-Wen Chang, Tai-Tsung Chang, Min-Sheng Lee, Yu-Te Chu, Chih-Hsing Hung

Published in: Inflammation | Issue 6/2008

Login to get access

Abstract

Low vitamin C and reduced alpha-carotene intake are associated with increased asthma risk in children. In addition, mean serum vitamin A concentrations are significantly lower in asthmatic children than in controls. All-trans retinoic acid (ATRA) is a derivative of vitamin A. Macrophage-derived chemokine (MDC) is a T helper cell-type 2 (Th2)-related chemokine involved in the recruitment of Th2 cells toward inflammatory sites. On the other hand, Th1-related chemokine, interferon-inducible protein 10 (IP-10)/CXCL10 is also important in allergic inflammation. Both Th1- and Th2-related chemokines play an important role in allergic asthma. To survey whether ATRA and ascorbic acid effect Th1- and Th2-related chemokine expression in monocytes. To test this, THP-1 cells were pre-treated with ATRA or ascorbic acid and stimulated by lipopolysaccharide (LPS) or poly I:C. Supernatants were measured for Th2-related (MDC) and Th1-related (IP-10) chemokine concentrations by ELISA. The effects of ATRA on mitogen-activated protein kinase (MAPK) and NFkb were evaluated with Western blotting. After stimulation, ATRA significantly down-regulated MDC and IP-10 in a dose-dependent manner. Similarly, ascorbic acid reduced the LPS-induced changes in MDC but only with a high dose. However, asorbic acid had no effect on IP-10 changes either induced by LPS or poly I:C. RT-PCR showed ATRA inhibited IP-10 expression through decreasing the level of transcription. Furthermore, ATRA suppressed the expression of LPS-stimulated c-Raf, MKK1/2 and ERK expression of THP-1 cells. In conclusion, ATRA suppressed Th2- and Th1-related chemokines expression in THP-1 cells, at least in part via the c-Raf-MKK1/2-ERK/MAPK pathway.
Literature
1.
go back to reference Barnes, P. J., K. F. Chung, and C. P. Page. 1998. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50:515–596.PubMed Barnes, P. J., K. F. Chung, and C. P. Page. 1998. Inflammatory mediators of asthma: an update. Pharmacol. Rev. 50:515–596.PubMed
5.
go back to reference Takamura, K., Y. Nasuhara, M. Kobayashi, T. Betsuyaku, Y. Tanino, I. Kinoshita, E. Yamaguchi, S. Matsukura, R. P. Schleimer, and M. Nishimura. 2004. Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L777–L785. doi:10.1152/ajplung.00289.2003.PubMedCrossRef Takamura, K., Y. Nasuhara, M. Kobayashi, T. Betsuyaku, Y. Tanino, I. Kinoshita, E. Yamaguchi, S. Matsukura, R. P. Schleimer, and M. Nishimura. 2004. Retinoic acid inhibits interleukin-4-induced eotaxin production in a human bronchial epithelial cell line. Am. J. Physiol. Lung Cell Mol. Physiol. 286:L777–L785. doi:10.​1152/​ajplung.​00289.​2003.PubMedCrossRef
8.
go back to reference Hung, C. H., C. Y. Li, Y. S. Lai, P. C. Hsu, Y. M. Hua, and K. D. Yang. 2005. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma. Pediatr. Allergy Immunol. 16:306–309.PubMed Hung, C. H., C. Y. Li, Y. S. Lai, P. C. Hsu, Y. M. Hua, and K. D. Yang. 2005. Discrepant clinical responses and blood chemokine profiles between two non-steroidal anti-inflammatory medications for children with mild persistent asthma. Pediatr. Allergy Immunol. 16:306–309.PubMed
11.
go back to reference Tudhope, S. J., T. K. Finney-Hayward, A. G. Nicholson, R. J. Mayer, M. S. Barnette, P. J. Barnes, and L. E. Donnelly. 2008. Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage. J. Pharmacol. Exp. Ther. 324:306–312. doi:10.1124/jpet.107.127670.PubMedCrossRef Tudhope, S. J., T. K. Finney-Hayward, A. G. Nicholson, R. J. Mayer, M. S. Barnette, P. J. Barnes, and L. E. Donnelly. 2008. Different mitogen-activated protein kinase-dependent cytokine responses in cells of the monocyte lineage. J. Pharmacol. Exp. Ther. 324:306–312. doi:10.​1124/​jpet.​107.​127670.PubMedCrossRef
14.
go back to reference Marks, G. B., S. Mihrshahi, A. S. Kemp, E. R. Tovey, K. Webb, C. Almqvist, R. D. Ampon, D. Crisafulli, E. G. Belousova, C. M. Mellis, J. K. Peat, and S. R. Leeder. 2006. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J. Allergy Clin. Immunol. 118:53–61. doi:10.1016/j.jaci.2006.04.004.PubMedCrossRef Marks, G. B., S. Mihrshahi, A. S. Kemp, E. R. Tovey, K. Webb, C. Almqvist, R. D. Ampon, D. Crisafulli, E. G. Belousova, C. M. Mellis, J. K. Peat, and S. R. Leeder. 2006. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J. Allergy Clin. Immunol. 118:53–61. doi:10.​1016/​j.​jaci.​2006.​04.​004.PubMedCrossRef
15.
go back to reference Dawson, H. D., G. Collins, R. Pyle, M. Key, A. Weeraratna, V. Deep-Dixit, C. N. Nadal, and D. D. Taub. 2006. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 7:27. doi:10.1186/1471-2172-7-27.PubMedCrossRef Dawson, H. D., G. Collins, R. Pyle, M. Key, A. Weeraratna, V. Deep-Dixit, C. N. Nadal, and D. D. Taub. 2006. Direct and indirect effects of retinoic acid on human Th2 cytokine and chemokine expression by human T lymphocytes. BMC Immunol. 7:27. doi:10.​1186/​1471-2172-7-27.PubMedCrossRef
16.
go back to reference Kull, I., A. Bergström, E. Melén, G. Lilja, M. van Hage, G. Pershagen, and M. Wickman. 2006. Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood. J. Allergy Clin. Immunol. 118:1299–1304. doi:10.1016/j.jaci.2006.08.022.PubMedCrossRef Kull, I., A. Bergström, E. Melén, G. Lilja, M. van Hage, G. Pershagen, and M. Wickman. 2006. Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood. J. Allergy Clin. Immunol. 118:1299–1304. doi:10.​1016/​j.​jaci.​2006.​08.​022.PubMedCrossRef
22.
go back to reference Wark, P. A., F. Bucchieri, S. L. Johnston, P. G. Gibson, L. Hamilton, J. Mimica, G. Zummo, S. T. Holgate, J. Attia, A. Thakkinstian, and D. E. Davies. 2007. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 120:586–593. doi:10.1016/j.jaci.2007.04.046.PubMedCrossRef Wark, P. A., F. Bucchieri, S. L. Johnston, P. G. Gibson, L. Hamilton, J. Mimica, G. Zummo, S. T. Holgate, J. Attia, A. Thakkinstian, and D. E. Davies. 2007. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J. Allergy Clin. Immunol. 120:586–593. doi:10.​1016/​j.​jaci.​2007.​04.​046.PubMedCrossRef
23.
go back to reference Sugiyama, T., K. Hoshino, M. Saito, T. Yano, I. Sasaki, C. Yamazaki, S. Akira, and T. Kaisho. 2008. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Int. Immunol. 20:1–9. doi:10.1093/intimm/dxm112.PubMedCrossRef Sugiyama, T., K. Hoshino, M. Saito, T. Yano, I. Sasaki, C. Yamazaki, S. Akira, and T. Kaisho. 2008. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7. Int. Immunol. 20:1–9. doi:10.​1093/​intimm/​dxm112.PubMedCrossRef
Metadata
Title
Effects of All-Trans Retinoic Acid on Th1- and Th2-Related Chemokines Production in Monocytes
Authors
Yu-Chien Tsai
Hui-Wen Chang
Tai-Tsung Chang
Min-Sheng Lee
Yu-Te Chu
Chih-Hsing Hung
Publication date
01-12-2008
Publisher
Springer US
Published in
Inflammation / Issue 6/2008
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-008-9095-x

Other articles of this Issue 6/2008

Inflammation 6/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.